1Savelli G, Lucignani G, Seregni E, et al. Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic(GEP) neuroendocrine tumours. Nucl Med Commun. 2004, 25(5):445.
2Giammarile F, Houzard C, Bournaud C, et al. Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. Eur J Endocrinol. 2004, 150(3):277.
3Grewal R, Dadparvar S, Yu J, et al. Efficacy of Tc-99m depreotide scintigraphy in evaluation of solitary pulmonary nodules. Cancer J. 2002, 8(5):400.
4Schillaci O, Spanu A, Scopinaro F, et al. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2003, 44(3):359.
5Baudin E, Lumbroso J, Schlumberger M, et al. Comparision of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med. 1996, 37(6):912.
6Tisell L, Ahlman H, Wangberg B, et al. Somatostatin receptor scintigraphy in medullary thyroid carcinoma. Br J Surg. 1997, 84(4):543.
7Berna L, Chico A, Matias-Guiu X, et al. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma. Eur J Nucl Med. 1998, 25(11):1482.
8Michele D, Elisabeth S, Boris P, et al. Nical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and meck. J Nucl Med. 2003, 44(11):1767.
9Christian M, Karl H, Bohuslavizki, et al. Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas. J Nucl Med. 2001,42:1338.
10Nicolato A. 111Indium-octreotide brain scintigraphy: a prognostic factor in skull base meningiomas treated with gamma knife radiosurgery. J Nucl Med. 2004, 48(1):26.
4McCance RA.Osteomalacia with Looser's nodes (Milkman's syndrome) due to raised resistance to vitamin D acquired about the age of 15 years[J].Q J Med,1947,16(61):33-47.
